<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="175">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04420468</url>
  </required_header>
  <id_info>
    <org_study_id>APHP200632</org_study_id>
    <nct_id>NCT04420468</nct_id>
  </id_info>
  <brief_title>Descriptive and Retrospective Analysis of Acute Myocarditis Associated With Pandemic COVID-19 in Children</brief_title>
  <acronym>HEART-COVID</acronym>
  <official_title>Descriptive and Retrospective Analysis of Acute Myocarditis Associated With Pandemic COVID-19 in Children</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study objectives are to descript clinical, biological and echocardiographic features of
      an acute myocarditis in children in the context of COVID-19 and to identify the underlying
      mechanism : direct viral damage and/or inadequate host response risk.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      An unexpected increase of shock with fever in children suspected to be infect by the COVID-19
      is observed. These children present with similar symptoms and seem to have similar clinical
      time course.

      This unexpected phenomenon needs to be extensively described in order to further the
      knowledge of unusual COVID-19 presentation in children.

      The study consists an extensive retrospective data collection from April 2020 till the end of
      the main SARS-Cov-2 outbreak, from medical file of children have exhibited acute myocarditis
      and cared in 4 pediatric intensive care units of Assistance Publique-Hôpitaux de Paris of
      Ile-de-France region.

      The study objectives are to descript clinical, biological and echocardiographic features of
      an acute myocarditis in children in the context of COVID-19 and to identify the underlying
      mechanism : direct viral damage and/or inadequate host response risk.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 2020</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Acute myocarditis</measure>
    <time_frame>7 days</time_frame>
    <description>Occurrence, description and time course of acute myocarditis</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Multi-systemic inflammatory syndrome</measure>
    <time_frame>7 days</time_frame>
    <description>Occurrence, description and time course of multi-systemic inflammatory syndrome, features of Kawasaki disease</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Kawasaki disease</measure>
    <time_frame>7 days</time_frame>
    <description>Occurrence, description and time course of features of Kawasaki disease</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Results of SARS-CoV-2</measure>
    <time_frame>7 days</time_frame>
    <description>Results of SARS-CoV-2 screening either by PCR or antibodies serological assay</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">20</enrollment>
  <condition>COVID-19</condition>
  <arm_group>
    <arm_group_label>Possible COVID-19 infection and acute myocarditis</arm_group_label>
    <description>Children presented with an acute myocarditis, fever and shock with a possible COVID-19 infection cared between April 2020 till the end of the main SARS-Cov-2 outbreak in 4 AP-HP Parisian hospitals :
Necker-Enfants Malades
Armand Trousseau
Robert Debré
Kremlin Bicêtre</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Children presented with an acute myocarditis, fever and shock with a possible COVID-19
        infection cared between April 2020 till the end of the main SARS-Cov-2 outbreak in 4 AP-HP
        Parisian hospitals :

          -  Necker-Enfants Malades

          -  Armand Trousseau

          -  Robert Debré

          -  Kremlin Bicêtre
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &lt; 18 years

          -  Admitted to PICU from April 2020

          -  Presented with an acute myocarditis, fever and shock with a possible COVID-19
             infection

        Exclusion Criteria:

          -  Age ≥ 18 years

          -  Other etiologies of acute myocarditis than the COVID-19

          -  Opposition expressed by the holders of parental authority
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marion Grimaud</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistance Publique - Hôpitaux de Paris</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sylvain Renolleau, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Assistance Publique - Hôpitaux de Paris</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Marion Grimaud, MD</last_name>
    <phone>1 87 89 20 19</phone>
    <phone_ext>+33</phone_ext>
    <email>marion.grimaud@aphp.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Hélène Morel</last_name>
    <phone>1 71 19 63 46</phone>
    <phone_ext>+33</phone_ext>
    <email>helene.morel@aphp.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hôpital Bicêtre</name>
      <address>
        <city>Le Kremlin-Bicêtre</city>
        <zip>94270</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Clémence Marais, MD</last_name>
      <email>clemence.marais@aphp.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital Armand Trousseau</name>
      <address>
        <city>Paris</city>
        <zip>75012</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Julie Starck, MD</last_name>
      <email>julie.starck@aphp.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital Necker-Enfants Malades</name>
      <address>
        <city>Paris</city>
        <zip>75015</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Marion Grimaud, MD</last_name>
      <phone>1 87 89 20 19</phone>
      <phone_ext>+33</phone_ext>
      <email>marion.grimaud@aphp.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital Robert Debré</name>
      <address>
        <city>Paris</city>
        <zip>75019</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Michäel Levy, MD</last_name>
      <email>michael.levy@aphp.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>June 5, 2020</study_first_submitted>
  <study_first_submitted_qc>June 5, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 9, 2020</study_first_posted>
  <last_update_submitted>June 5, 2020</last_update_submitted>
  <last_update_submitted_qc>June 5, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>COVID-19</keyword>
  <keyword>Acute myocarditis</keyword>
  <keyword>Children</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myocarditis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

